Peer Review reports
From: In silico drug repositioning based on integrated drug targets and canonical correlation analysis
| Original Submission | ||
|---|---|---|
| 18 Sep 2021 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 31 Oct 2021 | Reviewed | Reviewer Report |
| 21 Nov 2021 | Reviewed | Reviewer Report |
| 15 Dec 2021 | Author responded | Author comments - Hailin Chen |
| Resubmission - Version 3 | ||
| 15 Dec 2021 | Submitted | Manuscript version 3 |
| 10 Jan 2022 | Reviewed | Reviewer Report |
| 14 Jan 2022 | Reviewed | Reviewer Report |
| 25 Jan 2022 | Author responded | Author comments - Hailin Chen |
| Resubmission - Version 4 | ||
| 25 Jan 2022 | Submitted | Manuscript version 4 |
| 18 Feb 2022 | Reviewed | Reviewer Report |
| 21 Feb 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Publishing | ||
| 2 Mar 2022 | Editorially accepted | |
| 6 Mar 2022 | Article published | 10.1186/s12920-022-01203-1 |
You can find further information about peer review here.